Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Infectious Diseases
|
May 30, 2025
Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials
Ruth N Moro, John L Johnson, Neil Martinson, et al.
Plos One
|
May 3, 2013
Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment
Mary A De Groote, Payam Nahid, Leah Jarlsberg, et al.
Tuberculosis (Edinburgh, Scotland)
|
March 18, 2014
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis
Payam Nahid, Erin Bliven-Sizemore, Leah G Jarlsberg, et al.
Annals of the American Thoracic Society
|
March 20, 2013
The association between symptoms and microbiologically defined response to tuberculosis treatment
Craig M Hales, Charles M Heilig, Richard Chaisson, et al.
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial
Susan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
Emerging Infectious Diseases
|
January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020
Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.
Contemporary Clinical Trials
|
September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design
Ekaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The New England Journal of Medicine
|
May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Infectious Diseases
|
May 30, 2025
Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials
Ruth N Moro, John L Johnson, Neil Martinson, et al.
Plos One
|
May 3, 2013
Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment
Mary A De Groote, Payam Nahid, Leah Jarlsberg, et al.
Tuberculosis (Edinburgh, Scotland)
|
March 18, 2014
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis
Payam Nahid, Erin Bliven-Sizemore, Leah G Jarlsberg, et al.
Annals of the American Thoracic Society
|
March 20, 2013
The association between symptoms and microbiologically defined response to tuberculosis treatment
Craig M Hales, Charles M Heilig, Richard Chaisson, et al.
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial
Susan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
Emerging Infectious Diseases
|
January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020
Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.
Contemporary Clinical Trials
|
September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design
Ekaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The New England Journal of Medicine
|
May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Page
of 2